ClinicalTrials.gov record
Withdrawn Phase 2 Interventional

ENACT: A Study of ENX-101 as Adjunctive Treatment in Patients With Focal Seizures

ClinicalTrials.gov ID: NCT05481905

Public ClinicalTrials.gov record NCT05481905. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 6:21 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

The ENACT Trial: A Randomized, Double-blind, Placebo-controlled Adjunctive Treatment Trial to Evaluate the Efficacy and Safety of ENX-101 in Patients With Focal (Partial Onset) Seizures

Study identification

NCT ID
NCT05481905
Recruitment status
Withdrawn
Study type
Interventional
Phase
Phase 2
Lead sponsor
Engrail Therapeutics INC
Industry
Enrollment
Not listed

Conditions and interventions

Conditions

Interventions

  • ENX-101 Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2022
Primary completion
Aug 31, 2024
Completion
Nov 30, 2024
Last update posted
Jul 5, 2023

2022 – 2024

United States locations

U.S. sites
38
U.S. states
22
U.S. cities
34
Facility City State ZIP Site status
Barrow Neurological Institute Phoenix Arizona 85013
University of Arizona Tucson Arizona 85724
Rancho Research Institute at Rancho Los Amigos National Rehabilitation Center Downey California 90242
University of Colorado Aurora Colorado 80045
University of Florida Research Institute of Orlando Gainesville Florida 32611
Royal Care Medical Research Corporation Miami Florida 33032
University of Miami Miami Florida 33136
D&H National Research Centers Miami Florida 33155
S&G Research Center Corp. Miami Florida 33155
Florida Hospital Orlando Florida 32803
Comprehensive Neurology Clinic Orlando Florida 32825
Emory University School of Medicine Atlanta Georgia 30322
Hawaii Pacific Neuroscience Honolulu Hawaii 96817
OSF HealthCare Illinois Neurological Institute Peoria Illinois 61603
University of Kansas Kansas City Kansas 66160
Saint Joseph Health System Lexington Kentucky 40504
Maine Medical Partners Neurology Scarborough Maine 04074
University of Maryland Medical Center Baltimore Maryland 21201
Mid-Atlantic Epilepsy and Sleep Center Bethesda Maryland 20817
University of Michigan Ann Arbor Michigan 48109
Oakland University William Beaumont School of Medicine Farmington Hills Michigan 48334
SRI International Plymouth Michigan 48170
Advanced Clinical Research Center Bridgeton Missouri 63044
Washington University School of Medicine St Louis Missouri 63110
Somnos Clinical Research/Neurology Associates Lincoln Nebraska 68510
Northeast Regional Epilepsy Group Hackensack New Jersey 07601
Institute of Neurology and Neurosurgery at Saint Barnabas LLC Livingston New Jersey 07039
Donald and Barbara Zucker School of Medicine at Hofstra/Northwell New York New York 10016
University of Rochester Rochester New York 14618
Montefiore Medical Center The Bronx New York 10467
Atrium Health Chapel Hill North Carolina 28204
Duke University School of Medicine Durham North Carolina 27710
NeuroScience Research Center, LLC Canton Ohio 44718
Thomas Jefferson University Philadelphia Pennsylvania 42101
University of Pittsburgh Pittsburgh Pennsylvania 15213
DJL Clinical Research Rock Hill South Carolina 29732
Mt. Olympus Medical Research Sugar Land Texas 77479
University of Virginia Charlottesville Virginia 22908

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05481905, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 5, 2023 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05481905 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →